GFI’s comment applauds USDA and FDA’s commitment to working together to ensure the safety of cultivated meat. Learn why we support the joint regulatory framework.
GFI Policy Director Jessica Almy discusses pivotal developments in plant-based and cell-based meat regulation, illuminates key work by the GFI policy team along the way, and lays out what still needs to be done.
Mark the date: November 16, 2018 was the day that clean/cell-based meat's path to market became much clearer in the United States. On that day, the FDA and USDA announced details of how they will oversee clean/cell-based meat from cows, pigs, chickens, and turkeys.
GFI Executive Director Bruce Friedrich breaks down why governments and research institutions should be as excited about plant-based and clean meat as venture capitalists and the private sector are. Maybe even more excited.
USDA and FDA held a joint public meeting on to advance the conversation around clean meat regulation. GFI advocated firmly for a fair regulatory path to market under the existing regulatory structures. Our friends at JUST, Finless Foods, BlueNalu, UPSIDE Foods, and many others joined the conversation as well.
We weigh in on FDA's initiative to review its regulatory approach to nutrition and improve standards of identity, labeling claims, and ingredient information in the 21st Century.
We partnered with BlueNalu, Mosa Meat, Seafuture, and SuperMeat to share our thoughts on clean meat regulation with the FDA.
GFI’s comment requests FDA to clarify the role of standards of identity. Learn how flexible standards support innovation and consumer choice.
GFI’s comment explains the need for a clear regulatory pathway for cultivated meat. Learn more about cultivated meat and why FDA is well situated to ensure its safety.
Earlier this year, the Missouri governor signed an omnibus bill that contained language prohibiting "misrepresenting" any product as "meat" that does not come from a slaughtered animal. We just went to court to stop it.
